Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Alzheimer's disease
3. Vaccination against AD
4. Radial arm water maze
5. Vaccination prevents memory deficits in mice
6. Memory deficits correlate with amyloid-beta levels
7. Clinical trial of anti-amyloid-beta vaccine
8. Antibodies against amyloid-beta are efficacious
9. Where to go?
10. Mechanisms of antibody-mediated clearance
11. Catalytic fibril dissolution
12. Opsonization/Phagocytosis
13. Peripheral sink hypothesis
14. Administration of antibodies into old mice
15. Diffuse and compact amyloid deposits
16. Anti-amyloid-beta antibody labels plaques
17. Antibodies decrease amyloid-beta immunostaining
18. Antibodies reduce congophilic deposits
19. Parenchymal and vascular amyloid deposits
20. Anti-amyloid-beta increases vascular amyloid
21. Microhemorrhages increase with immunization
22. Behavioral benefits are retained
23. Immunotherapy may have a problem
24. A possible solution
25. Deglycosylated 2H6 does not activate microglia
26. Deglycosylated anti-amyloid-beta 2H6
27. Systemic administration experimental design
28. Antibodies reverse cognitive decline
29. 2H6 causes a greater increase in vascular amyloid
30. Intact 2H6 results in more microhemorrhages
31. Key points
32. Histopathology - Elan-Wyeth phase 1 trial
33. Bapineuzumab phase 1
34. Bapineuzumab phase 2 trial results
35. Current trials of Amyloid-beta immunotherapy
36. Prospects for immunotherapy

Topics Covered

• Alzheimer's Disease
• Immunization with amyloid-beta (A-beta)
• Radial arm water maze
• Clinical trial of anti-A-beta vaccine
• Mechanisms of antibody-mediated A-beta clearance
• Catalytic fibril dissolution
• Peripheral sink hypothesis
• Systemic administration of anti-A-beta antibodies into old APP transgenic (Tg) mice
• Diffuse and compact amyloid deposits
• Systemic anti-A-beta antibody
• Parenchymal and vascular amyloid deposits
• Microhemorrhages
• A possible solution to the problems of immunotherapy
• Systemic administration experimental design
• Intact and deglycosylated antibodies reverse cognitive decline
• Current clinical trials of A-beta immunotherapy
• Prospects for immunotherapy

Links

Series:

• Alzheimer's Disease

Categories:

• Clinical Practice
• Immunology
• Neuroscience

Therapeutic Areas:

• Immunology & Inflammation
• Neurology

Talk Citation

Morgan, D. (2010, August 26). Immunotherapy as an approach to treating Alzheimer's disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/CKBY5624.
Export Citation (RIS)

Publication History

• Published on August 26, 2010

Financial Disclosures

• Prof. David Morgan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.